Screener
BioMarin Pharmaceuticals BMRN Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by BioMarin Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent.
The source filing: BioMarin Pharmaceuticals’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:14 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001048477-26-000016
| ASSETS | June 30, 2026 / (unaudited) | December 31, 2025 ⁽¹⁾ |
|---|---|---|
| Current assets: | ||
| Cash and cash equivalents | $874,005 | $1,311,679 |
| Short-term investments | — | 248,930 |
| Accounts receivable, net | 1,061,047 | 908,214 |
| Inventory | 1,782,524 | 1,298,883 |
| Other current assets | 254,047 | 185,784 |
| Total current assets | 3,971,623 | 3,953,490 |
| Noncurrent assets: |
Item 1. Financial Statements
FAQ
- What is BioMarin Pharmaceuticals's short-term investments?
- BioMarin Pharmaceuticals (BMRN) reported short-term investments of $0 in Q2 2026.
- How has BioMarin Pharmaceuticals's short-term investments changed year-over-year?
- BioMarin Pharmaceuticals's short-term investments decreased by 100.0% year-over-year, from $218.31M to $0.
- What is the long-term trend for BioMarin Pharmaceuticals's short-term investments?
- Over 5 years (2020 to 2025), BioMarin Pharmaceuticals's short-term investments has grown at a -9.8% compound annual growth rate (CAGR), from $416.23M to $248.93M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.
Ask your AI about BioMarin Pharmaceuticals's short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude